Babson Diagnostics (BetterWay)

Babson Diagnostics is a healthcare technology company founded in 2017 and based in Austin, TX, focused on making routine blood testing friendly, convenient, and affordable. Their primary consumer offering, BetterWay, launched in May 2024, enables fingertip-based capillary blood collection requiring only about one-tenth of the blood needed for traditional venous draws. BetterWay uses the FDA-cleared BD MiniDraw™ Capillary Blood Collection System and is available in retail pharmacy settings, with plans to expand into ambulatory care across the United States. Babson has strategic partnerships with Becton, Dickinson and Company and Siemens Healthineers, and collaborates with Orchard Software for laboratory information management.

Traditional blood testing requires venous draws that are invasive, inconvenient, and often discourage patients from getting routine tests. This reduces patient adherence and limits access to preventive diagnostics.

BetterWay offers a fingertip capillary blood collection process using the FDA-cleared BD MiniDraw™ system, requiring only a fraction of the blood of a typical draw. The service is deployed in accessible retail pharmacy settings to improve convenience and patient adherence.

BetterWay launched in May 2024 in retail pharmacy settings. Babson has raised approximately $44.7M in total funding across Series A, Series B, and a subsequent venture round from investors including Siemens Healthineers, BD, Prizm Ventures, and others. The company has ~55 employees.